Francois A. Menard, SVP, Global Generics R&D at WATSON PHARMACEUTICALS INC (WPI), sold 3,467 shares at $73.89 ($256K) on 2012-05-29, disclosed to the SEC on 2012-05-30.
Open-market sale of $256k WPI by SVP, Global Generics R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.